Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Pain × Naproxen × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Diseases 1 Pain 1 Leiomyoma 1 Inflammation 1 Hyperuricemia 1 Gout 1 Dysmenorrhea 1 Cardiovascular Diseases 1 Arthritis 1

Interventions

Fentanyl 7 Acetaminophen 5 Zoledronic Acid 4 Oxycodone 4 Bupivacaine 4 Sufentanil 3 Ketamine 3 Hydromorphone 3 Diclofenac 3 Ropivacaine 2 Pregabalin 2 Ketorolac 2 Ibuprofen 2 Ibandronic Acid 2 Esketamine 2 Epinephrine 2 naloxegol 1 chloroprocaine 1 acetaminophen, aspirin, caffeine drug combination 1 Varenicline 1 Uterine Artery Embolization 1 Ultracet 1 Therapeutics 1 Propofol 1 Pamidronate 1 Naproxen 1 Morphine 1 Methadone 1 Meperidine 1 Lidocaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04145518 2025-12-12

MCUP

Endeavor Health

Phase 4 Completed

Dysmenorrhea, Leiomyoma, Pain, Uterine Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡